Pierre Country
    • Homepage
Altesa BioSciences’ Treatment for Rhinovirus Infections in People with Respiratory Conditions, Vapendavir, Selected for Oral Presentation at the International Society for Antiviral Research Conference (ICAR) 2026

Author: Altesa Biosciences Inc.

Posted Date:

March 19, 2026
  • Altesa BioSciences’ Treatment for Rhinovirus Infections in People with Respiratory Conditions, Vapendavir, Selected for Oral Presentation at the International Society for Antiviral Research Conference (ICAR) 2026

    Altesa Biosciences Inc.
    March 19, 2026
  • Altesa BioSciences Closes Oversubscribed $75 Million Series B Financing to Transform Treatment of Chronic Lung Diseases

    Altesa Biosciences Inc.
    February 19, 2026